The reported potential addition of Chinese investors emerged as the current $23 billion deal has hit regulatory roadblocks.

The firm anticipates that private investment and technology businesses will contribute over 30% of its revenue by 2030.

Lisa Pratta was a sales rep for drug manufacturer Questcor then she became a whistleblower. She witnessed bribes and was screamed at to illegally sell a multiple sclerosis drug. So she went ...